Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,449,029
+$841,702 QoQ
Shares Held
25,628
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.37%
of 13F equity value
Holder Rank
#1,157
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Raab & Moskowitz Asset Management LLC holds $28,665,612 across 9 Drug Manufacturers - General names. ABBV ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
51,773 | $6,652,830 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
25,628 | $6,449,029 | |
| 3 | JNJ |
Johnson & Johnson
|
22,910 | $5,818,452 | |
| 4 | PFE |
Pfizer Inc
|
226,116 | $5,444,873 | |
| 5 | LLY |
ELI LILLY & Co
|
1,809 | $2,169,769 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
16,300 | $939,206 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,144 | $523,552 | |
| 8 | SNY |
Sanofi
|
9,307 | $397,036 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,449,029 | 25,628 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,607,327 | 25,782 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $6,028,023 | 26,382 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $6,030,227 | 26,044 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $4,865,100 | 26,210 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,465,957 | 26,088 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,673,865 | 26,302 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,235,984 | 26,514 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $4,533,788 | 26,433 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,849,140 | 26,629 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,128,710 | 26,642 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $4,019,402 | 26,965 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $3,635,419 | 26,983 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,374,706 | 27,450 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,518,130 | 27,957 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,761,637 | 28,028 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,333,355 | 28,293 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,561,937 | 28,141 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,807,583 | 28,121 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,033,412 | 28,121 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $3,239,301 | 28,758 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $3,057,864 | 28,256 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,202,330 | 11,221 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,009,124 | 11,521 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,167,262 | 11,889 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $896,908 | 11,772 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||